Dr Karan Explores

GLP-1 Pizzas, Drops & Telehealth Scams - What’s Really Going On? | Dr. Spencer Nadolsky

Mar 5, 2026
Guest
Spencer Nadolsky
Dr. Spencer Nadolsky, a board-certified physician and obesity/GLP-1 researcher, breaks down the GLP-1 craze. He debunks GLP-1–branded foods and risky telehealth compounding. Short practical tips on nausea, alcohol, supplements, and why next-gen drugs like retatrutide matter are discussed in clear, fast-paced conversation.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

GLP-1s Reshape Restaurant And Grocery Demand

  • Widespread GLP-1 use is changing consumer behaviour and hurting restaurant and takeout spending.
  • Nadolsky notes users order smaller portions, skip desserts, and some grocery spending drops, altering food industry demand.
INSIGHT

GLP-1s Often Reduce Alcohol Use

  • GLP-1s commonly reduce alcohol desire and binge drinking, potentially lowering alcohol-related harms.
  • Nadolsky links receptor effects and reduced tolerance early on, and observes patients often stop drinking or drink less.
INSIGHT

No Clear Pancreatitis Signal In Big Trials

  • Large trials and meta-analyses show no clear increased pancreatitis signal from GLP-1s versus placebo.
  • Nadolsky points out confounders like rapid weight loss and gallstones can cause pancreatitis, not necessarily the drugs themselves.
Get the Snipd Podcast app to discover more snips from this episode
Get the app